Pilot Phase II Study of 5-Azacytidine in Previously Treated Patients With Advanced NSCLC
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Azacitidine (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacogenomic; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 12 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Nov 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.